Author

Jiandong Zhou

University of Hong KongORCID 0000-0003-3780-9033Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:statistical model· 1

Frequent Co-Authors

Lei LüiD· 2 shared David Andrew CliftoniD· 1 shared Gary TseiD· 1 shared Guoliang LiiD· 1 shared Lin Shen· 1 shared Oscar Hou In ChouiD· 1 shared Quinncy Lee· 1 shared Shuk Han ChengiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Lei LüORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringIEEE Journal of Biomedical and Health InformaticsPeer-reviewedFeb 12, 2025

AI-assisted In-silico Trial for the Optimization of Osmotherapy following Ischaemic Stroke

Xi Chen, Lei Lü, Tamás Józsa…·Stephen John Payne

This paper develops an AI-assisted in-silico trial to optimize osmotherapy protocols for ischaemic stroke by predicting intracranial pressure and personalizing treatment based on patient-specific data.

1 citation

humanclinical cohort / trial

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintSep 15, 2024

Genetic associations between SGLT2 inhibition, DPP4 inhibition or GLP1R agonism and prostate cancer risk: a two-sample Mendelian randomisation study

Lin Shen, Yifan Yang, Lei Lü…·Jiandong Zhou

This paper uses Mendelian randomization to find that SGLT2 and DPP4 inhibition are associated with reduced prostate cancer risk, but GLP1R agonism is not.

DOI 10.1101/2024.09.15.24313695

humanGWAS summary statistics

𝕏 PostBluesky